Correlative Decrease of Large Neurons in the Neostriatum and Basal Nucleus of Meynert in Alzheimer's Disease

Overview

Journal Brain Res

Specialty Neurology

Date 1989 Dec 18

PMID 2598036

Citations 11

Authors

K Oyanagi

H Takahashi

K Wakabayashi

F Ikuta

Affiliations

Soon will be listed here.

Abstract

A quantitative investigation was performed on the large neurons in the neostriatum and basal nucleus of Meynert (bnM) in patients with Alzheimer's disease (AD) and progressive supranuclear palsy (PSP). The degree of decrease of the large neurons in the neostriatum was quite similar to that in the bnM; these decreases were significantly correlative in AD, but not in PSP. These findings indicate that the large neurons in the neostriatum and bnM, which are considered to be cholinergic and to exclusively possess nerve growth factor receptors in the cerebrum, degenerate simultaneously in an equal ratio in AD.

Citing Articles

A New Neural Pathway from the Ventral Striatum to the Nucleus Basalis of Meynert with Functional Implication to Learning and Memory.

Shu S, Jiang G, Zheng Z, Ma L, Wang B, Zeng Q Mol Neurobiol. 2019; 56(10):7222-7233.

PMID: 31001802 PMC: 6728281. DOI: 10.1007/s12035-019-1588-0.

Dopamine and Serotonin-Induced Modulation of GABAergic and Glutamatergic Transmission in the Striatum and Basal Forebrain.

Momiyama T, Nishijo T Front Neuroanat. 2017; 11:42.

PMID: 28553205 PMC: 5425578. DOI: 10.3389/fnana.2017.00042.

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

Perez S, Dar S, Ikonomovic M, DeKosky S, Mufson E Neurobiol Dis. 2007; 28(1):3-15.

PMID: 17662610 PMC: 2245889. DOI: 10.1016/j.nbd.2007.06.015.

D1-like dopamine receptors selectively block P/Q-type calcium channels to reduce glutamate release onto cholinergic basal forebrain neurones of immature rats.

Momiyama T, Fukazawa Y J Physiol. 2007; 580(Pt 1):103-17.

PMID: 17234695 PMC: 2075417. DOI: 10.1113/jphysiol.2006.125724.

Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 transgenic mice.

Perez S, Lazarov O, Koprich J, Chen E, Rodriguez-Menendez V, Lipton J J Neurosci. 2005; 25(44):10220-9.

PMID: 16267229 PMC: 6725777. DOI: 10.1523/JNEUROSCI.2773-05.2005.